Malacañang on Monday urged the public to wait for the Food and Drug Administration (FDA) to act on an application for the use of Ivermectin as a potential anti-Covid medication.
Presidential Spokesperson Harry Roque made this statement after rejecting rumors that President Rodrigo Duterte had ordered the Department of Health (DOH) to authorize the use of Ivermectin.
“He did not. What happened is the IATF had a meeting on Saturday that lasted for almost 10 hours and one of the agendas we discussed was Ivermectin,” he said in a Palace press briefing in Filipino.
Citing FDA Director General Eric Domingo, Roque said a firm has already applied for the compassionate use of Ivermectin.
“Usec. Domingo, Director General of the FDA said that there is an application for the compassionate use of Ivermectin,” he said in Filipino.
Roque, however, reminded the public to wait for FDA action on the application.
“The FDA can process that application, unlike before when nobody has applied for it yet. So let’s wait for the FDA action on the application for the use of Ivermectin,” he added in Filipino.
On March 26, the DOH and the FDA warned against the purchase and use of Ivermectin veterinary products to treat Covid-19.
In a joint announcement, the two agencies said the FDA has not received any applications for the use of Ivermectin for Covid-19 treatment under the Compassionate Special Permit.
“At present, Ivermectin veterinary products are only approved for use in the prevention of heartworm disease and treatment of internal and external parasites in certain animal species,” the announcement read.
The DOH earlier warned doctors who prescribe the use of Ivermectin as a treatment for Covid-19 that their names will be submitted to the Professional Regulation Commission (PRC), and if found guilty, may have their licenses revoked.It said the FDA has only evaluated Ivermectin’s safety and efficacy in particular species in its label and that using the product in humans “can cause serious harm.” SOVEREIGNPH